InvestorsObserver
×
News Home

Market Reactions to FibroGen Inc (FGEN) Stock Getting a Bearish Rating

Wednesday, July 01, 2020 12:00 PM | InvestorsObserver Analysts

Mentioned in this article

Market Reactions to FibroGen Inc (FGEN) Stock Getting a Bearish Rating

The market has been down on FibroGen Inc (FGEN) stock recently. FGEN gets a Bearish score from InvestorsObserver's Stock Sentiment Indicator.

Sentiment Score - ,bearish
FibroGen Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on FGEN!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company.

Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.

InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.

Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With FGEN Stock Today?

FibroGen Inc (FGEN) stock is trading at $41.58 as of 11:57 AM on Wednesday, Jul 1, a gain of $1.05, or 2.59% from the previous closing price of $40.53. The stock has traded between $40.29 and $41.89 so far today. Volume today is low. So far 104,417 shares have traded compared to average volume of 842,017 shares.

To screen for more stocks like FibroGen Inc click here.

More About FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App